Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Cholesterol drug setback casts doubt over multibillion-dollar race

Novartis’ failure raises the stakes for Amgen and Eli Lilly in the race to turn lower Lp(a) levels into fewer heart attacks and strokes.

We haven't written up this one. CNBC has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at cnbc.com →

More in Finance & Markets

More from Tuesday 8 September →